Trials
1 active
3 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “Single intradiscal injection of 1 mL of 9,000,000 cells/mL IDCT in a single target disc.”In the company’s words, NCT07254806 on ClinicalTrials.gov
- Tested for
- Degenerative Disc Disease
- Main trialPhase 3
- “This is a Phase III, randomized, double-blinded, Sham-controlled, multi-center study in subjects with single-level, symptomatic lumbar (L3- S1) intervertebral disc degeneration. The study will have a 52-week primary period followed by 52 week Follow-up Period (total of 104 weeks). The study protocol will be approved by the Institutional Review Board (IRB) or Independent Ethics Committee (IEC), and the study will be conducted in accordance with Good Clinical Practice (GCP). All subjects will provide written informed consent prior to Screening. Approximately 162 subjects will be enrolled in…”In the company’s words, NCT07254806 on ClinicalTrials.gov
- Other names
- Injectable Disc Cell Therapy
Other drugs for Degenerative Disc Disease
- Rexlemestrocel-LMesoblast, Ltd. · Phase 3
- MDT-0123Medtronic Spinal and Biologics · Phase 3
- SB-01Spine BioPharma, Inc · Phase 3
- ANPCASTEROGENE Biomedical Co. Ltd. · Phase 1/2
- BRTX-100BioRestorative Therapies · Phase 2
- CELZ-201-DDTCreative Medical Technology Holdings Inc · Phase 1/2
Coming up1
- 24 Nov 2027Phase 3 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials3
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Recruiting | 24 Nov 2027 | A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc Disease | |
| Phase 1Completed | 1 Feb 2022 | Study to Evaluate the Safety and Preliminary Efficacy of IDCT, a Treatment for Symptomatic Lumbar Intervertebral Disc Degeneration | |
| Phase 1Completed | 1 Feb 2022 | Study to Evaluate the Safety and Preliminary Efficacy of IDCT, a Treatment for Symptomatic Lumbar Disc Degeneration |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026